U-78517F (2-[4-[2,6-di-(1-pyrrolidinyl)-4-pyridinyl)-1-piperazinyl] methyl]-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-
benzopyran-6-ol, dihydrochloride), which combines the
antioxidant ring portion of
alpha-tocopherol together with the
amine of the previously described 21-aminosteroids (e.g.,
U-74006F), is a novel inhibitor of
iron-catalyzed lipid peroxidation.
U-78517F was found to have a 50% inhibitory concentration (IC50) of 0.6 microM against 200 microM
ferrous chloride-initiated lipid peroxidation in rat brain homogenates, compared to 8 microM for
U-74006F, 28 microM for
alpha-tocopherol and 43 microM for the ring portion of
alpha-tocopherol (i.e.,
trolox). Both stereoisomers of the racemic
U-78517F proved to be equally active
antioxidants. Against lipid peroxidation initiated by
xanthine/
xanthine oxidase,
U-78517F was even more potent, with an IC50 of 0.01 microM.
U-78517F was also observed to protect cultured mouse spinal neurons against
iron-induced damage, with an IC50 of approximately 0.5 microM. When administered to male CF-1 mice i.v. at 5 min after a severe concussive
head injury.
U-78517F produced a dose-related improvement in the 1-hr neurological recovery. The minimum effective i.v. dose was 1.0 micrograms/kg. Measurement of U-78517 concentrations in the brains of mice after administration of
a 10-mg/kg i.v. dose revealed effective
antioxidant levels for as long
as 2 hr. Evidence of an in vivo
antioxidant action was provided by the attenuation of
iron-induced blood-brain barrier disruption (i.e.,
Evans' blue extravasation) in rats pretreated with
U-78517F.(ABSTRACT TRUNCATED AT 250 WORDS)